M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
... SAN DIEGO Feb. 27 /- Ocera Therapeutics abiopharma... We are delighted by Scott's addition to our team and find his academi... Adding Scott to the team comes at a key time for the company as weap...Dr. Harris has served in several clinical development and medicalaffa...
Date:2/27/2008
SAN DIEGO, Feb. 27 /PRNewswire/ -- Ocera Therapeutics, a
biopharmaceutical company focused on the licensing, development and
commercialization of proprietary compounds to treat a broad range of
gastrointestinal and liver diseases, announced today that M. Scott Harris,
M.D., has joined the company as Chief Medical Officer. Prior to joining
Ocera, Dr. Harris held the position of Chief Medical Officer and Vice
President of Clinical Affairs at Napo Pharmaceuticals. Dr. Harris has
extensive experience in gastrointestinal diseases as well as clinical and
regulatory operations.
"We are delighted by Scott's addition to our team and find his academic
credentials, clinical practice treating patients suffering from
Inflammatory Bowel Disease and his clinical development experience to be a
great fit for Ocera," stated Laurent Fischer, M.D., co-founder, President
and CEO of Ocera Therapeutics. "Scott brings a wealth of experience in the
gastroenterology space, with a particular focus in Crohn's disease as well
as practical expertise in all stages of drug development and
commercialization."
"Adding Scott to the team comes at a key time for the company as we
approach the results of our pivotal Phase 3 trial for Crohn's disease,"
commented Eckard Weber, M.D., partner at Domain Associates, co-founder of
Ocera and chairman of the board. "We look forward to his added guidance and
expertise in this pivotal stage of the company's growth."
Dr. Harris has served in several clinical development and medical
affairs roles within the industry. He was a principal and vice president of
pharmaceutical research and development at Middleburg Consultants where he
served as a clinical and regulatory consultant to pharmaceutical companies.
He also served as the global director of clinical development for Otsuka
America. Dr. Harris held senior-level positions at Abbott Laboratories and
Schwarz Pharma, Inc.
"Ocera is an excellent example of a company with a focused de
'/>"/>
SOURCE Ocera Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved | |
Page: 1 2 Related biology technology :1.
L&M Healthcare Communications, LLC, Hires Scott Karasinski, PharmD2.
Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration3.
Anaptys Biosciences Appoints R. Scott Greer to Board of Directors4.
Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)5.
Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics6.
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer7.
Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors8.
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer9.
Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire10.
MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board11.
Royea Joins Eklin Medical Systems as VP of Worldwide Sales
(Date:11/30/2009)...ire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Na...ug Administration (FDA) has granted orphan drug de...mpridine phosphate, for the rare autoimmune diseas...AP has previously received orphan drug designation... for Medicinal Products for Human Use of the Europ...
(Date:11/30/2009)...0 ApaTech, the rapidly growing,ort...owing,Biotech/Pharmaceutical/Medical Technology/Eq...st 500 for EMEA (Europe, Middle East and Africa). ...nies, five-year revenue growth,for which ApaTech ...is,achievement places ApaTech 9th overall in the r...
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...ak at Economic Club of Canada , ...- Ambassador to Speak at Economic Club of Canada.,...International Investment, and Chairman and CEO of ...f David Appia go to www.investinfrance.org . , ,...h press to discuss recent pro-business initiatives...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3French Ambassador for International Investment to Visit Toronto December 11 2...NTA (Oct. 8, 2007) -- Nanoscale devices present a ...es just not enough room for light to travel in a s...roduced by radiating photons of light between two ...s 10 nanometers), smaller than the wavelength of t...noscale as its wavelength is interrupted, producin...
...on of Drug Pipeline and Advancement of Clinical Pr... Inc.,(OTC Bulletin Board: AVGO), a late-stage bio...ystem therapeutics for neurodegenerative,disorders...pany at the 4th,Annual BIO InvestorForum Conferenc...l of San Francisco. The company,s chief executive ...
...TON, Fla., Oct. 8 Biomedtex Inc. (Pink,Sheets: BM...company,announced today: BIOMEDTEX INC: The Comp...a broad,spectrum of global medical technologies, a...and promote innovations with significant commercia...visit us at http://WWW.BIOMEDTEX.COM Safe Harbo...
Other Biology Technology:Taming tiny, unruly waves for nano optics 2Avicena to Present at 4th Annual BIO InvestorForum Conference 2(Date:11/30/2009)...ehensive review of the state of Antarctica,s clima...em is published this week (Tuesday 1 December) by ...AR). The review - Antarctic Climate Change and th...he icy continent, identifies areas for future scie...s that policy makers have about Antarctic melting,...
(Date:11/30/2009)...versity of Pittsburgh team overcame a major hurdle... those that could lead to more efficient catalysts...ess toxic. The researchers reported Nov. 29 in Na...mperature stability in metallic nanoparticles, the...ulnerability to extreme heat. , Gtz Veser, an as...
(Date:11/30/2009)...The Journal of Experimental Biology are pleased ...onal de la Recherche Scientifique (CNRS) in the Un...this year,s JEB Outstanding Paper Prize. ,The pr...hievement and is intended to encourage young scien...hief, and adds that ,we truly appreciate when auth...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Grant supports LSUHSC research on how like cell receptor systems determine very different functions 9344 1Grant supports LSUHSC research on how like cell receptor systems determine very different functions 9344 2Wanted 3A Orange County California Licensed Pharmacy Technicians 52671 1Wanted 3A Orange County California Licensed Pharmacy Technicians 52671 2Wanted 3A Orange County California Licensed Pharmacy Technicians 52671 3Government Officials Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 52669 1Government Officials Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 52669 2Molecular Virology from Promega
GIBCO Newborn Calf Serum from Invitrogen
Bovine Calf Blood Non-Sterile Alsevers from Pel-Freez Biologicals
Computer and Monitor for GSD-501 from Invitrogen
Biology Products: 